Trail making test B in postoperative delirium: a replication study.

Geriatric anaesthesia Open science Perioperative medicine Postoperative delirium Replication Risk prediction Trail making test

Journal

BJA open
ISSN: 2772-6096
Titre abrégé: BJA Open
Pays: England
ID NLM: 9918419157906676

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 24 05 2023
revised: 28 08 2023
accepted: 16 10 2023
medline: 13 11 2023
pubmed: 13 11 2023
entrez: 13 11 2023
Statut: epublish

Résumé

The Trail Making Test B (TMT-B) is indicative of cognitive flexibility and several other cognitive domains. Previous studies suggest that it might be associated with the risk of developing postoperative delirium, but evidence is limited and conflicting. We therefore aimed to replicate the association of preoperative TMT-B results with postoperative delirium. We included older adults (≥65 yr) scheduled for major surgery and without signs of dementia to participate in this binational two-centre longitudinal observational cohort study. Presurgical TMT-B scores were obtained. Delirium was assessed twice daily using validated instruments. Logistic regression was applied and the area under the receiver operating characteristic curve calculated to determine the predictive performance of TMT-B. We subsequently included covariates used in previous studies for consecutive sensitivity analyses. We further analysed the impact of outliers, missing or impaired data. Data from 841 patients were included and of those, 151 (18%) developed postoperative delirium. TMT-B scores were statistically significantly associated with the incidence of postoperative delirium {odds ratio per 10-s increment 1.06 (95% confidence interval [CI] 1.02-1.09), The TMT-B was associated with postoperative delirium, but its predictive performance as a stand-alone test was low. The TMT-B alone is not suitable to predict delirium in a clinical setting. NCT02265263. (https://clinicaltrials.gov/ct2/show/results/NCT02265263).

Sections du résumé

Background UNASSIGNED
The Trail Making Test B (TMT-B) is indicative of cognitive flexibility and several other cognitive domains. Previous studies suggest that it might be associated with the risk of developing postoperative delirium, but evidence is limited and conflicting. We therefore aimed to replicate the association of preoperative TMT-B results with postoperative delirium.
Methods UNASSIGNED
We included older adults (≥65 yr) scheduled for major surgery and without signs of dementia to participate in this binational two-centre longitudinal observational cohort study. Presurgical TMT-B scores were obtained. Delirium was assessed twice daily using validated instruments. Logistic regression was applied and the area under the receiver operating characteristic curve calculated to determine the predictive performance of TMT-B. We subsequently included covariates used in previous studies for consecutive sensitivity analyses. We further analysed the impact of outliers, missing or impaired data.
Results UNASSIGNED
Data from 841 patients were included and of those, 151 (18%) developed postoperative delirium. TMT-B scores were statistically significantly associated with the incidence of postoperative delirium {odds ratio per 10-s increment 1.06 (95% confidence interval [CI] 1.02-1.09),
Conclusions UNASSIGNED
The TMT-B was associated with postoperative delirium, but its predictive performance as a stand-alone test was low. The TMT-B alone is not suitable to predict delirium in a clinical setting.
Clinical trial registration UNASSIGNED
NCT02265263. (https://clinicaltrials.gov/ct2/show/results/NCT02265263).

Identifiants

pubmed: 37954892
doi: 10.1016/j.bjao.2023.100239
pii: S2772-6096(23)00118-1
pmc: PMC10633257
doi:

Banques de données

ClinicalTrials.gov
['NCT02265263']

Types de publication

Journal Article

Langues

eng

Pagination

100239

Informations de copyright

© 2023 The Author(s).

Références

Science. 2015 Aug 28;349(6251):aac4716
pubmed: 26315443
Eur J Anaesthesiol. 2017 Apr;34(4):192-214
pubmed: 28187050
Anesthesiology. 2009 Apr;110(4):781-7
pubmed: 19326492
Front Aging Neurosci. 2021 Jun 07;13:676734
pubmed: 34163350
BMC Bioinformatics. 2006 Mar 09;7:123
pubmed: 16526949
J Am Geriatr Soc. 2006 Jun;54(6):937-41
pubmed: 16776789
Elife. 2021 May 10;10:
pubmed: 33970101
Anesthesiology. 2017 Nov;127(5):765-774
pubmed: 28891828
PLoS Biol. 2020 Mar 27;18(3):e3000691
pubmed: 32218571
Nat Rev Neurosci. 2013 May;14(5):365-76
pubmed: 23571845
Commun Biol. 2021 Sep 17;4(1):1099
pubmed: 34535753
Neuropsychol Rev. 2007 Sep;17(3):213-33
pubmed: 17786559
PLoS Med. 2007 Oct 16;4(10):e296
pubmed: 17941714
Front Aging Neurosci. 2022 Oct 14;14:911088
pubmed: 36313029
J Clin Epidemiol. 1996 Aug;49(8):907-16
pubmed: 8699212
Front Aging Neurosci. 2015 Jun 09;7:112
pubmed: 26106326
Annu Rev Psychol. 2022 Jan 4;73:719-748
pubmed: 34665669
Nat Protoc. 2006;1(5):2277-81
pubmed: 17406468
Br J Anaesth. 2019 Oct;123(4):464-478
pubmed: 31439308
Nat Rev Dis Primers. 2020 Nov 12;6(1):90
pubmed: 33184265
J Clin Psychol. 1998 Aug;54(5):585-91
pubmed: 9696108
BMC Res Notes. 2020 Feb 4;13(1):55
pubmed: 32019577
Elife. 2021 Dec 07;10:
pubmed: 34874005
Eur Psychiatry. 2018 Apr;50:34-39
pubmed: 29398565
Int J Geriatr Psychiatry. 2019 Jul;34(7):1018-1028
pubmed: 30907449
Anesthesiology. 2009 Apr;110(4):788-95
pubmed: 19326494
Lancet. 2014 Mar 8;383(9920):911-22
pubmed: 23992774

Auteurs

Marinus Fislage (M)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Berlin, Germany.
Department of Neurology, National Taiwan University Hospital, Taipei, China.

Insa Feinkohl (I)

Witten/Herdecke University, Faculty of Health/School of Medicine, Witten, Germany.
Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Molecular Epidemiology Research Group, Berlin, Germany.

Friedrich Borchers (F)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Berlin, Germany.

Maria Heinrich (M)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.

Tobias Pischon (T)

Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Molecular Epidemiology Research Group, Berlin, Germany.
Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Biobank Technology Platform, Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Core Facility Biobank, Berlin, Germany.

Dieuwke S Veldhuijzen (DS)

Health, Medical and Neuropsychology Unit, Leiden University, Leiden, the Netherlands.
Leiden Institute for Brain and Cognition, Leiden, the Netherlands.

Arjen J C Slooter (AJC)

Department of Psychiatry, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Department of Intensive Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Department of Neurology, UZ Brussel and Vrije Universiteit Brussel, Brussels, Belgium.

Claudia D Spies (CD)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Berlin, Germany.

Georg Winterer (G)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Berlin, Germany.
Pharmaimage Biomarker Solutions GmbH, Berlin, Germany.

Norman Zacharias (N)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Berlin, Germany.
Pharmaimage Biomarker Solutions GmbH, Berlin, Germany.

Classifications MeSH